Lataa...
Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation
BACKGROUND: The clinical use of chromatin-modulating drugs, such as histone deacetylase inhibitors, for the treatment of bone marrow failure and hematopoietic malignancies has increased dramatically over the last few years. Nonetheless, little is currently known concerning their effects on myelopoie...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ferrata Storti Foundation
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2895027/ https://ncbi.nlm.nih.gov/pubmed/20107159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.008870 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|